Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Carla Crespo

Physician Assistant Marina Del Rey, CA Physician Assistant

NPI 1205964020 CMS profile 11204149

4640 Admiralty Way Ste 1000, Marina Del Rey, CA 90292

Open in the dashboard

General payments

$297,137

762 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Carla Crespo of Marina Del Rey, CA is reported in the CMS Open Payments database as having received $297,137 across 762 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $37,078 117
2024 General $64,590 168
2023 General $50,849 105
2022 General $59,580 155
2021 General $85,040 217

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Carla Crespo
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Carla Crespo were reported at $37,078. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Carla Crespo Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $85,040 $132 $37–$438 $132
2022 $59,580 $155 $48–$522 $149
2023 $50,849 $167 $52–$557 $160
2024 $64,590 $178 $55–$600 $164
2025 $37,078 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $134,567 340 payments
  2. Allergan Inc. $107,956 276 payments
  3. Galderma Laboratories, L.P. $54,165 129 payments
  4. Revance Therapeutics, Inc. $227 10 payments
  5. Merz North America, Inc. $222 7 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $275,124 137 payments
  2. Food and Beverage $12,593 436 payments
  3. Travel and Lodging $9,354 188 payments
  4. Education $67 1 payment
Products named General payments · program years 2021–2025
  1. BOTOX $103,026 313 payments
  2. KYBELLA $500 1 payment
  3. DYSPORT $300 3 payments
  4. DAXXIFY $227 10 payments
  5. DYSPORT $81 5 payments
  6. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $55 2 payments
  7. Xeomin $44 2 payments
  8. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $10 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

762 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record